Hepatitis C Trust: Newshttp://www.hepctrust.org.uk/News_Resources/news/2012New Jefferson Hepatitis C Center in the UShttp://www.hepctrust.org.uk/News_Resources/news/2012/May/New+Jefferson+Hepatitis+C+Center+in+the+USTue, 15 May 2012 13:49:05 GMThttp://www.hepctrust.org.uk/2vne-2f-2fPx4cEGUaH9ezNhWoQ-3d-3dtesting@cubik.co.uk;monitoring@mazarsit.co.ukAchillion initiates dosing in Phase I hepatitis C virus trialhttp://www.hepctrust.org.uk/News_Resources/news/2012/May/Achillion+initiates+dosing+in+Phase+I+hepatitis+C+virus+trialTue, 15 May 2012 09:35:07 GMThttp://www.hepctrust.org.uk/2Vbawdk2560KmvaD1loNs2Q-3d-3dtesting@cubik.co.uk;monitoring@mazarsit.co.ukRibavirin Helps Early Hepatitis C Treatment in People with HIVhttp://www.hepctrust.org.uk/News_Resources/news/2012/May/Ribavirin+Helps+Early+Hepatitis+C+Treatment+in+People+with+HIVTue, 15 May 2012 08:44:02 GMThttp://www.hepctrust.org.uk/26B7OEbj1OE-2bZTpgNje-2f5Yw-3d-3dtesting@cubik.co.uk;monitoring@mazarsit.co.ukHep C and HIV virtual online learning lectureshttp://www.hepctrust.org.uk/News_Resources/news/2012/May/Hep+C+and+HIV+virtual+online+learning+lecturesFri, 11 May 2012 09:19:11 GMThttp://www.hepctrust.org.uk/29cBLpQcjUk2ODEIBi7Qigw-3d-3dtesting@cubik.co.uk;monitoring@mazarsit.co.ukHepatitis C cases reach record level in Lothianshttp://www.hepctrust.org.uk/News_Resources/news/2012/May/Hepatitis+C+cases+reach+record+level+in+LothiansThu, 10 May 2012 11:57:09 GMThttp://www.hepctrust.org.uk/2cQlIXoW77kaJv01WZ3X39A-3d-3dtesting@cubik.co.uk;monitoring@mazarsit.co.ukFDA Update Safety Information On HIV Drug Victrelis (Boceprevir)http://www.hepctrust.org.uk/News_Resources/news/2012/May/FDA+Update+Safety+Information+On+HIV+Drug+Victrelis+BoceprevirThu, 10 May 2012 08:48:07 GMThttp://www.hepctrust.org.uk/22iEIJKVKt0aKOUnuQas7lA-3d-3dtesting@cubik.co.uk;monitoring@mazarsit.co.ukAdverse drug reaction reporting goes onlinehttp://www.hepctrust.org.uk/News_Resources/news/2012/May/Adverse+drug+reaction+reporting+goes+onlineTue, 08 May 2012 10:03:18 GMThttp://www.hepctrust.org.uk/2JF3-2br4dcWkW3SyBqnpnbKQ-3d-3dtesting@cubik.co.uk;monitoring@mazarsit.co.ukA summary of the European Liver meeting 2012http://www.hepctrust.org.uk/News_Resources/news/2012/May/A+summary+of+the+European+Liver+meeting+2012Tue, 08 May 2012 09:48:24 GMThttp://www.hepctrust.org.uk/2Kc50O0gAwU2MFjCYHZBUIw-3d-3dtesting@cubik.co.uk;monitoring@mazarsit.co.ukNew drug news from EASLhttp://www.hepctrust.org.uk/News_Resources/news/2012/April/New+drug+news+from+EASLTue, 01 May 2012 14:32:05 GMThttp://www.hepctrust.org.uk/2y9epJsCLNUenj0wtk-2f-2f4zw-3d-3dtesting@cubik.co.uk;monitoring@mazarsit.co.ukShould I wait for new treatments?http://www.hepctrust.org.uk/News_Resources/news/2012/April/Should+I+wait+for+new+treatmentsTue, 01 May 2012 12:57:52 GMThttp://www.hepctrust.org.uk/2qbisoYVSkUSFeZl3QaFV7Q-3d-3dtesting@cubik.co.uk;monitoring@mazarsit.co.ukIncidence of hepatitis C re-infection and clearance may be understimatedhttp://www.hepctrust.org.uk/News_Resources/news/2012/April/Incidence+of+hepatitis+C+re+infection+and+clearance+may+be+understimatedMon, 30 Apr 2012 11:49:12 GMThttp://www.hepctrust.org.uk/2dA0sFpTj9k6VjQ5QaCgl9g-3d-3dtesting@cubik.co.uk;monitoring@mazarsit.co.ukContaminated Blood Campaignhttp://www.hepctrust.org.uk/News_Resources/news/2012/April/Contaminated+Blood+CampaignThu, 26 Apr 2012 15:36:18 GMThttp://www.hepctrust.org.uk/2d4I-2f0-2fYEmEO1R15rc04ypQ-3d-3dtesting@cubik.co.uk;monitoring@mazarsit.co.ukThe Hepatitis C Trust beats over 350 applicants to prestigious awardhttp://www.hepctrust.org.uk/News_Resources/news/2012/April/The+Hepatitis+C+Trust+beats+over+350+applicants+to+prestigious+awardThu, 26 Apr 2012 14:30:06 GMThttp://www.hepctrust.org.uk/29PYQ3XmK60WG77FtHZV-2fEw-3d-3dtesting@cubik.co.uk;monitoring@mazarsit.co.ukFinding weak point in armor of Hepatitis C provides target for new drugs against deadly virushttp://www.hepctrust.org.uk/News_Resources/news/2012/April/Finding+weak+point+in+armor+of+Hepatitis+C+provides+target+for+new+drugs+against+deadly+virusThu, 26 Apr 2012 11:22:02 GMThttp://www.hepctrust.org.uk/2d2pZ2AT81U6HenUF9WFe-2fQ-3d-3dtesting@cubik.co.uk;monitoring@mazarsit.co.ukBoceprevir and Telaprevir are now appoved for use within the NHS in the UKhttp://www.hepctrust.org.uk/News_Resources/news/2012/April/Boceprevir+and+Telaprevir+are+now+appoved+for+use+within+the+NHS+in+the+UKWed, 25 Apr 2012 06:00:00 GMThttp://www.hepctrust.org.uk/2JnQ1qoAmS0yHmIlXiLBCOA-3d-3dtesting@cubik.co.uk;monitoring@mazarsit.co.ukPublic Lecture in Oxford on Hep Chttp://www.hepctrust.org.uk/News_Resources/news/2012/April/Public+Lecture+in+Oxford+on+Hep+CTue, 24 Apr 2012 14:10:00 GMThttp://www.hepctrust.org.uk/2Q8g-2f5FF-2b90yRyLf3UJbimA-3d-3dtesting@cubik.co.uk;monitoring@mazarsit.co.ukMobile hepatitis C screening to be held in four Warwickshire townshttp://www.hepctrust.org.uk/News_Resources/news/2012/April/Mobile+hepatitis+C+screening+to+be+held+in+four+Warwickshire+townsTue, 24 Apr 2012 12:39:04 GMThttp://www.hepctrust.org.uk/2HRPxjbnppUajARVVuAUQeA-3d-3dtesting@cubik.co.uk;monitoring@mazarsit.co.ukHepatitis C testing available for residents of Warwickshirehttp://www.hepctrust.org.uk/News_Resources/news/2012/April/Hepatitis+C+testing+available+for+residents+of+WarwickshireMon, 23 Apr 2012 14:23:32 GMThttp://www.hepctrust.org.uk/2ps5oVq8DT0OoBiI1iHZzTw-3d-3dtesting@cubik.co.uk;monitoring@mazarsit.co.ukTelaprevir and Boceprevir Effective but Cause Serious Side Effects in Patients With Cirrhosishttp://www.hepctrust.org.uk/News_Resources/news/2012/April/Telaprevir+and+Boceprevir+Effective+but+Cause+Serious+Side+Effects+in+Patients+With+CirrhosisMon, 23 Apr 2012 11:30:12 GMThttp://www.hepctrust.org.uk/2W6QNqfddKU6ufJBHaYMbHw-3d-3dtesting@cubik.co.uk;monitoring@mazarsit.co.uk82% Hepatitis C Cure Rate Achieved In Large Trialhttp://www.hepctrust.org.uk/News_Resources/news/2012/April/82+Hepatitis+C+Cure+Rate+Achieved+In+Large+TrialMon, 23 Apr 2012 10:30:22 GMThttp://www.hepctrust.org.uk/2LMoYObWb5U6hlhLM-2b239Cg-3d-3dtesting@cubik.co.uk;monitoring@mazarsit.co.uk